Target Price | $205.72 |
Price | $153.36 |
Potential | 34.14% |
Number of Estimates | 57 |
57 Analysts have issued a price target Alphabet 2026 . The average Alphabet target price is $205.72. This is 34.14% higher than the current stock price. The highest price target is $250.00 63.02% , the lowest is $159.00 3.68% . | |
A rating was issued by 68 analysts: 56 Analysts recommend Alphabet to buy, 12 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Alphabet stock has an average upside potential 2026 of 34.14% . Most analysts recommend the Alphabet stock at Purchase. |
57 Analysts have issued a sales forecast Alphabet 2025 . The average Alphabet sales estimate is $388b . This is 10.85% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $400b 14.34% , the lowest is $368b 5.34% .
This results in the following potential growth metrics:
2024 | $350b | 13.89% |
---|---|---|
2025 | $388b | 10.85% |
2026 | $429b | 10.76% |
2027 | $474b | 10.38% |
2028 | $511b | 7.84% |
2029 | $582b | 13.77% |
37 Analysts have issued an Alphabet EBITDA forecast 2025. The average Alphabet EBITDA estimate is $171b . This is 32.39% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $179b 38.72% , the lowest is $162b 25.74% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $127b | 29.97% |
---|---|---|
2025 | $171b | 33.82% |
2026 | $194b | 13.78% |
2027 | $221b | 13.99% |
2028 | $243b | 9.89% |
2029 | $290b | 19.15% |
2024 | 36.45% | 14.13% |
---|---|---|
2025 | 44.00% | 20.73% |
2026 | 45.20% | 2.73% |
2027 | 46.68% | 3.27% |
2028 | 47.56% | 1.89% |
2029 | 49.81% | 4.73% |
61 Alphabet Analysts have issued a net profit forecast 2025. The average Alphabet net profit estimate is $108b . This is 9.60% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $121b 22.86% , the lowest is $98.5b 0.25% .
This results in the following potential growth metrics and future Net Margins:
2024 | $98.2b | 38.62% |
---|---|---|
2025 | $108b | 9.74% |
2026 | $123b | 14.11% |
2027 | $141b | 14.83% |
2028 | $155b | 9.56% |
2029 | $190b | 22.89% |
2024 | 28.07% | 21.72% |
---|---|---|
2025 | 27.78% | 1.02% |
2026 | 28.63% | 3.06% |
2027 | 29.78% | 4.02% |
2028 | 30.25% | 1.58% |
2029 | 32.68% | 8.03% |
61 Analysts have issued a Alphabet forecast for earnings per share. The average Alphabet EPS is $8.82 . This is 9.57% higher than earnings per share in the financial year 2024. The highest EPS forecast is $9.89 22.86% , the lowest is $8.07 0.25% .
This results in the following potential growth metrics and future valuations:
2024 | $8.04 | 38.62% |
---|---|---|
2025 | $8.82 | 9.70% |
2026 | $10.07 | 14.17% |
2027 | $11.56 | 14.80% |
2028 | $12.67 | 9.60% |
2029 | $15.57 | 22.89% |
Current | 19.06 | 30.49% |
---|---|---|
2025 | 17.38 | 8.81% |
2026 | 15.23 | 12.37% |
2027 | 13.27 | 12.87% |
2028 | 12.11 | 8.74% |
2029 | 9.85 | 18.66% |
Based on analysts' sales estimates for 2025, the Alphabet stock is valued at an EV/Sales of 4.65 and an P/S ratio of 4.82 .
This results in the following potential growth metrics and future valuations:
Current | 5.15 | 16.67% |
---|---|---|
2025 | 4.65 | 9.77% |
2026 | 4.20 | 9.71% |
2027 | 3.80 | 9.40% |
2028 | 3.52 | 7.27% |
2029 | 3.10 | 12.10% |
Current | 5.34 | 17.06% |
---|---|---|
2025 | 4.82 | 9.79% |
2026 | 4.35 | 9.71% |
2027 | 3.94 | 9.41% |
2028 | 3.66 | 7.27% |
2029 | 3.21 | 12.10% |
Analyst | Rating | Action | Date |
---|---|---|---|
Morgan Stanley |
Overweight
➜
Overweight
|
Unchanged | Apr 17 2025 |
Truist Securities |
Buy
➜
Buy
|
Unchanged | Apr 17 2025 |
BMO Capital |
Outperform
➜
Outperform
|
Unchanged | Apr 17 2025 |
Cantor Fitzgerald |
Neutral
➜
Neutral
|
Unchanged | Apr 16 2025 |
Needham |
Buy
➜
Buy
|
Unchanged | Apr 16 2025 |
DA Davidson |
Neutral
➜
Neutral
|
Unchanged | Apr 14 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Apr 10 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Morgan Stanley:
Overweight
➜
Overweight
|
Apr 17 2025 |
Unchanged
Truist Securities:
Buy
➜
Buy
|
Apr 17 2025 |
Unchanged
BMO Capital:
Outperform
➜
Outperform
|
Apr 17 2025 |
Unchanged
Cantor Fitzgerald:
Neutral
➜
Neutral
|
Apr 16 2025 |
Unchanged
Needham:
Buy
➜
Buy
|
Apr 16 2025 |
Unchanged
DA Davidson:
Neutral
➜
Neutral
|
Apr 14 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Apr 10 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.